SCHEMBL9125102

SCHEMBL9125102

Cc1cc(C)c(COc2cccnc2NC(N)=Nc2ccc(Cl)cc2)c(C)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPIA P62937 9/20 0.42
SIGMAR1 Q99720 2/20 0.40
PPIF P30405 1/20 0.38
ACHE P22303 1/20 0.36
RAB9A P51151 2/20 0.36
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
C5AR1 P21730 1/20 0.34
EPHA2 P29317 1/20 0.34
KDR P35968 1/20 0.34
EPHB4 P54760 1/20 0.34
SGMS2 Q8NHU3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9122341 0.85 PPIA (0.51) PPIASIGMAR1PPIFACHEGRIN2D
SCHEMBL9127905 0.85 PPIA (0.45) PPIASIGMAR1PPIFALDH1A1SMN1; SMN2
SCHEMBL9126127 0.84 PPIA (0.45) PPIASIGMAR1PPIFRAB9ASGMS2
SCHEMBL9124036 0.83 PPIF (0.48) PPIASIGMAR1PPIFALDH1A1SGMS2
SCHEMBL9128712 0.82 PPIA (0.43) PPIASIGMAR1PPIFALDH1A1SGMS2
SCHEMBL9125077 0.82 PPIA (0.62) PPIAPPIFC5AR1
SCHEMBL9125719 0.81 PPIA (0.40) PPIASIGMAR1PPIFRAB9AALDH1A1
SCHEMBL9127446 0.81 SGMS2 (0.46) PPIASIGMAR1PPIFRAB9AALDH1A1
SCHEMBL9124791 0.80 NPC1 (0.51) PPIASIGMAR1PPIFRAB9AALDH1A1
SCHEMBL9124960 0.80 PPIA (0.47) PPIASIGMAR1PPIFHPGDSGMS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5409943-A [(alkoxy)pyridinyl]amine compounds which are useful in the treatment of gastrointestinal disorders SMITHKLINE BEECHAM INTERCREDIT B.V. (NL) 1995-04-25 US disclosed